EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Extracellular vesicles in exhaled breath condensate as emerging biomarkers in lung cancer

Benjamin Schmidt, Coralie Tambon, Francesca Cortopassi, Carsten Bokemeyer, Meike J Saul iD

American Journal of Physiology-Cell Physiology · 01.07.2026 · 331 (1) · C101-C116

DOI: 10.1152/ajpcell.00069.2026 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift American Journal of Physiology-Cell Physiology, erschienen am 01.07.2026. Verfasst von Benjamin Schmidt und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine II, Oncology, Hematology, Bone Marrow Transplantation with Section Pneumology, University Medical Center Hamburg-Eppendorf, Ha…. Hauptthemen laut MEDLINE: Lung Neoplasms, Extracellular Vesicles, Biomarkers, Tumor, Exhalation. Die Arbeit nennt 170 Literaturangaben. Gefördert von: Hamburger Krebsgesellschaft (Hamburg Cancer Society), Deutsche Krebshilfe (German Cancer Aid).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Exhaled breath condensate (EBC) has emerged as a noninvasive liquid biopsy medium that captures aerosolized material from the respiratory tract and may provide insight into local lung biology. Within this matrix, extracellular vesicles (EVs) can carry DNA, RNA, proteins, and lipids that reflect cellular origin and may report tumor-associated inflammation, airway remodeling, and microenvironmental changes. This review summarizes current evidence on the molecular composition, origin, and biogenesis of EVs detected in EBC, with emphasis on their potential for early lung cancer detection and longitudinal disease monitoring. Proteomic, transcriptomic, and genomic analyses have identified tumor-associated signatures, including cytokines, driver mutations, and epigenetic alterations, whereas lipidomic profiling may capture oxidative, inflammatory, and metabolic stress. Recent methodological advances in EV enrichment, microfluidics, single-vesicle analytics, and digital assays are improving the sensitivity of low-biomass EBC analyses. However, EBC-derived EV research remains technically challenging, and standardization of collection, EV isolation, molecular analysis, and reporting is essential. Artificial intelligence (AI) and machine learning (ML) may support integration of multiomic and clinical data, particularly when validated in prospective cohorts. Together, these developments position EBC-derived EVs as an emerging, patient-friendly, lung-proximal platform for biomarker discovery and future precision oncology applications, while underscoring the need for source-resolved validation and clinical translation studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsExtracellular VesiclesBiomarkers, TumorExhalationHumansBreath TestsLiquid BiopsyAnimals

Stichwörter der Autor:innen

biomarkerexhaled breath condensateextracellular vesiclesliquid biopsylung cancer

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Medicine II, Oncology, Hematology, Bone Marrow Transplantation with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

ORCID-Profile: Meike J Saul

Förderung

  • Hamburger Krebsgesellschaft (Hamburg Cancer Society)
  • Deutsche Krebshilfe (German Cancer Aid)

Zitieren

APA

Schmidt, B., Tambon, C., Cortopassi, F., Bokemeyer, C., & Saul, M. J. (2026). Extracellular vesicles in exhaled breath condensate as emerging biomarkers in lung cancer. American Journal of Physiology-Cell Physiology, 331(1), C101-C116. https://doi.org/10.1152/ajpcell.00069.2026

Vancouver

Schmidt B, Tambon C, Cortopassi F, Bokemeyer C, Saul MJ. Extracellular vesicles in exhaled breath condensate as emerging biomarkers in lung cancer. American Journal of Physiology-Cell Physiology. 2026;331(1):C101-C116. doi:10.1152/ajpcell.00069.2026

BibTeX
@article{Schmidt2026,
  author = {Schmidt, Benjamin and Tambon, Coralie and Cortopassi, Francesca and Bokemeyer, Carsten and Saul, Meike J},
  title = {Extracellular vesicles in exhaled breath condensate as emerging biomarkers in lung cancer},
  journal = {American Journal of Physiology-Cell Physiology},
  year = {2026},
  volume = {331},
  number = {1},
  pages = {C101--C116},
  doi = {10.1152/ajpcell.00069.2026}
}
Kostenlos starten →